Who
Lawson Macartney
Director
Company insider
Files Form 4 as: Director, Viking Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 1
- Sells
- 4
- Bought
- $250K
- Sold
- $1.3M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 Apr 2015
- Last trade
- 2 Jan 2026
- Last filed
- 5 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 5 Jan 2026 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,150 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,400 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,400 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,150 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,800 at $0.00 | filing |
| 8 Nov 2024filed 8 Nov 2024 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,000 at $0.00 | filing |
| 8 Nov 2024filed 8 Nov 2024 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code M | $12K2,000 at $5.80 | filing |
| 8 Nov 2024filed 8 Nov 2024 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Sold | $137K2,000 at $68.67 | filing |
| 2 Jan 2024filed 4 Jan 2024 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 16 May 2023filed 18 May 2023 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,000 at $0.00 | filing |
| 16 May 2023filed 18 May 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code M | $19K16,000 at $1.19 | filing |
| 16 May 2023filed 18 May 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Sold | $384K16,000 at $24.00 | filing |
| 24 Apr 2023filed 24 Apr 2023 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,000 at $0.00 | filing |
| 24 Apr 2023filed 24 Apr 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code M | $53K16,000 at $3.33 | filing |
| 24 Apr 2023filed 24 Apr 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Sold | $352K16,000 at $22.00 | filing |
| 17 Apr 2023filed 18 Apr 2023 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,786 at $0.00 | filing |
| 17 Apr 2023filed 18 Apr 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Code M | $166K20,786 at $8.00 | filing |
| 17 Apr 2023filed 18 Apr 2023 | VKTX Viking TherapeuticsBiotechnology | SEC FORM 4 Sold | $416K20,786 at $20.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | VKTX Viking Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
News
Prediction: $1,000 Invested in Viking Therapeutics Today Will Be Worth This Much in 5 YearsVKTX · fool.com · 20 Oct 2026Viking Therapeutics Initiates Pivotal Phase 3 Trial: Here's Why Investors Have Reason for Optimism After a Disappointing Phase 2VKTX · fool.com · 20 Oct 2026Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.VKTX · fool.com · 18 Oct 2026
0 headlines in the last 90 days name Lawson Macartney; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.